Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

Taking off again in US .....

First 239 Last

Share
Profile

Follow
xlr82nulevels

63 Posts.

48

14/08/20

05:20

Post #: 46529280
Share

Originally posted by Rich&Poor: ↑

The authors for the abstract on Medical management of brain metastases, will correct their publication.
All 3 authors would be well aware of the drugs selected in ALLIANCE study, they will be very embarrassed with their lack of proof reading..

The study arms from the ALLIANCE study is as follows:-
"Experimental: Arm I (CDK gene mutation)Patients receive abemaciclib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.Intervention: Drug: Abemaciclib
Experimental: Arm II (PI3K gene mutation)Patients receive PI3K inhibitor GDC-0084 PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.Intervention: Drug: PI3K Inhibitor GDC-0084
Experimental: Arm III (NTRK/ROS1 gene mutation)Patients receive entrectinib PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.Intervention: Drug: Entrectinib"Regards.

Expand

Taking off again in US .....

KZA Price at posting: 77.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

IBG

Ironbark eyes lithium and niobium opportunities with 7 new Brazilian projects

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

PXX

Polarx discovers thick sulphide mineralisation at Alaskan Cu project

PGD

Peregrine extends high-grade gold shoot, sniffs anomalism at WA's Tin Can

There are more pages in this discussion • 32 more messages in this thread...

First 239 Last

Add KZA (ASX) to my watchlist